The Government accountability office (GAO) is examining companies that sell directly to consumers genetic tests. The investigation is centralized in important companies in the growing market of consumer genetic tests. This companies are 23 and Me, Navigenics, De Code Genetics and Pathway Genomics. During a hearing at the House Energy and Commerce Committees Investigation Gregory Kuts, managing director of forensic audits and special investigations described the GAO’s method. The results varied because each company uses different methods for analyzing the data. The director of the Food and Drug Administration (FDA) Center for Devices and Radiological Health Jeff Shuren, also testified at the hearing. Although genetic test has been sold online for years it was the intent of Walgreen’s to sell on their pharmacies the Path way company genetic test. The FDA is still determining the next steps in regulating the young direct to consumer genetic test market.
domingo, 27 de febrero de 2011
GAO investigates genetic test companies
Retrieved from http://ic.galegroup.com/ic/ovic/AcademicJournalsDetailsPage/AcademicJournalsDetailsWindow?displayGroupName=Journals&prodId=OVIC&action=e&windowstate=normal&catId=&documentId=GALE|A240623016&mode=view
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario